Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: WHAT IF THERE'S BAD NEWS? SHOULD THE BOD TELL SHAREHOLDERS?

they have made too many large mistakes and find it difficult to leave under these circumstances. It would concede defeat. Also, it's much too lucrative. As long as the shareholders let them get away with it, why not take big fees and options. They don't want anyone to spoil that.

Share
New Message
Please login to post a reply